Drugplain

Benzonatate 100 mg 100 mg/1

Benzonatate 100 mg · CAPSULE, LIQUID FILLED · MARKSANS PHARMA LIMITED

No Recall History
Plain English

Benzonatate 100 mg is a capsule, liquid filled containing benzonatate 100 mg at 100 mg/1, taken oral. Manufactured by MARKSANS PHARMA LIMITED.

Key Facts

Brand Name
Benzonatate 100 mg
Generic Name
Benzonatate 100 mg
NDC Code (Product)
25000-002
Manufacturer
MARKSANS PHARMA LIMITED
Strength
100 mg/1
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Marketing Status
Application #
ANDA220298
Drug Class
Non-narcotic Antitussive [EPC]
Marketing Start
04/10/2026

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

chills2 reports
diarrhoea2 reports
transaminases increased2 reports
unresponsive to stimuli2 reports
abdominal wall haematoma1 reports
alanine aminotransferase increased1 reports
aspartate aminotransferase increased1 reports
blood glucose increased1 reports
blood pressure decreased1 reports
bronchitis1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS & USAGE Benzonatate capsules are indicated for the symptomatic relief of cough.

Dosage & Administration

DOSAGE & ADMINISTRATION Adults and Children over 10 years of age: Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given. Benzonatate Capsules should be swallowed whole. Benzonatate Capsules are not to be broken, chewed, dissolved, cut or crushed.

Warnings

WARNINGS Hypersensitivity Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures. Psychiatric Effects Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking benzonatate in combination with other prescribed drugs. Accidental Ingestion and Death in Children Keep benzonatate capsules out of reach of children. Accidental ingestion of benzonatate resulting in death has been reported in children below age 10. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. If accidental ingestion occurs, seek medical attention immediately (see OVERDOSAGE)

Contraindications

CONTRAINDICATIONS Hypersensitivity to benzonatate or related compounds.

Adverse Reactions

ADVERSE REACTIONS Potential Adverse Reactions to benzonatate may include: Hypersensitivity reactions including bronchospasm, laryngospasm, cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule. CNS: sedation; headache; dizziness; mental confusion; visual hallucinations. GI: constipation; nausea; GI upset. Dermatologic: pruritus; skin eruptions. Other: nasal congestion; sensation of burning in the eyes; vague “chilly” sensation; numbness of the chest; hypersensitivity. Deliberate or accidental overdose has resulted in death, particularly in children.

Frequently Asked Questions

What is Benzonatate 100 mg used for?

Benzonatate 100 mg contains Benzonatate 100 mg. It is a capsule, liquid filled taken oral. Consult your doctor for specific uses.

Is Benzonatate 100 mg a controlled substance?

Benzonatate 100 mg is not classified as a controlled substance by the DEA.

What is the generic name for Benzonatate 100 mg?

The generic name for Benzonatate 100 mg is Benzonatate 100 mg. There are no other listed brand versions of Benzonatate 100 mg.

What is the NDC code for Benzonatate 100 mg 100 mg/1?

The NDC (National Drug Code) for Benzonatate 100 mg 100 mg/1 is 25000-002, listed by MARKSANS PHARMA LIMITED.

Product NDC

25000-002

Package NDC

25000-002-03

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)